AgomAb Therapeutics N.V. American Depositary Shares
NASDAQ:AGMBBiotechnology
+$0.25 today
- Market cap
- $286.62M
- Beta
- 2.62
- P/E (TTM)
- -7.1
- EPS (TTM)
- -$1.28
Volume 0.13M
Average 0.14M
AGMB Other Working Capital
Cash effect of changes in other operating assets and liabilities.
AgomAb Therapeutics N.V. American Depositary SharesNASDAQ: AGMB
Other Working Capital · Q4 FY2024 · quarter ended Dec 2024
Other working capital of -€1.62M in Q4 FY2024
Q4 FY2024 other working capital was -€1.62M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Working Capital history
Currency unavailable · from the cash flow
No Other Working Capital data reported for this period type.
Other Working Capital vs competitors
How AGMB compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
ALMSAlumis Inc. Common Stock | LTM Jun 2026 | $15.67M USD | -52.0% | — | 211.8% |
| LTM Mar 2026 | $12.8M USD | -157.3% | +91.3% | 153.0% | |
| LTM Mar 2026 | $1.92M USD | +150.9% | -48.7% | 0.8% | |
| LTM Mar 2026 | $278K USD | -285.3% | — | — | |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | — | — | — | — | — |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
| Peer median (excluding AGMB) | — | -104.7% | +21.3% | 153.0% | |
Competitors are the stored peer set for AGMB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
AgomAb Therapeutics N.V. American Depositary Shares
NASDAQ:AGMB
Intrinsic Alpha fair value
Locked
Current Price
$5.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.